Twenty four out of the 74 deregulated genes with altered expression in LGMD2A were also deregulated in other muscular dystrophies (DMD, α-SGD, FSHD, dysferlinopathies, Fukuyama-type congenital muscular dystrophy, and laminin-α2 deficient congenital muscular dystrophy) [24], [30]–[35] (Table 2). This evidence concerns the gene CAPN3 and facioscapulohumeral muscular dystrophy.